606 IMpower110: Tertiary lymphoid structures (TLS) and clinical outcomes in advanced non-small cell lung cancer (NSCLC) treated with first-line atezolizumab or chemotherapy

• Robert Johnston,
• Hartmut Koeppen,
• Roy S Herbst,
• Kurt Schalper,
• Filippo De Marinis,
• Giuseppe Giaccone,
• Jacek Jassem,
• Marcus Ballinger,
• Barani Kumar Rajendran,
• David R Spigel,
• Miguel López de Rodas,
• Minu K Srivastava,
• Jennifer M Giltnane,
• Barzin Y Nabet,
• David S Shames,
• Velimir Gayevskiy,
• Vy Ma,
• Ivette Estay,
• Tien Hoang,
• Reena Amin

Affiliations

Robert Johnston

Gloucestershire Eye Department, Cheltenham General Hospital, Cheltenham GL53 7AN

Hartmut Koeppen

1Genentech Inc., South San Francisco, CA, USA

Roy S Herbst

1Yale University, New Haven, CT, USA

Kurt Schalper

1Yale University, New Haven, CT, USA

Filippo De Marinis

4European Institute of Oncology, Milan, Italy

Giuseppe Giaccone

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA

Jacek Jassem

13Medical University of Gdansk, Gdansk, Poland

Marcus Ballinger

1Genentech Inc., South San Francisco, CA, USA

Barani Kumar Rajendran

3Yale School of Medicine, New Haven, CT, USA

David R Spigel

Department of Thoracic Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, USA

Miguel López de Rodas

1Yale University School of Medicine, New Haven, CT, USA

Minu K Srivastava

Genentech, South San Francisco, CA, USA

Jennifer M Giltnane

2Genentech Inc., South San Francisco, CA, USA

Barzin Y Nabet

Genentech, Inc., South San Francisco, CA, USA

David S Shames

1Genentech Inc., South San Francisco, CA, USA

Velimir Gayevskiy

1Genentech Inc, South San Francisco, CA, USA

Vy Ma

1Genentech Inc, South San Francisco, CA, USA

Ivette Estay

1Genentech Inc, South San Francisco, CA, USA

Tien Hoang

1Genentech Inc, South San Francisco, CA, USA

Reena Amin

1Genentech Inc, South San Francisco, CA, USA